YOUR CART
- No products in the cart.
Subtotal:
$0.00
BEST SELLING PRODUCTS
Connect with us
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF Interest & Corporate Loan Monitor May 2022”. FCF regularly conducts comprehensive research regarding the...
The head of a scaling, fast growth company wears many hats. Being the business’s corporate finance adviser doesn’t need to be one of them. Regular attendees...
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 04/2022”. The Monitor is a monthly published overview...
With 44 deals, the corporate venture arm of Boehringer Ingelheim was the most active corporate investor in the European life science market in the last five...
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 04/2022”.The Monitor is a monthly published overview...
Global M&A activity in 2021 easily surpassed the pre-pandemic level and nearly matched the peaks of 2015 and 2007. The number of announced M&A deals exceeded...
It is no surprise that the top 5 European investors have shown significantly higher activities than US investors in Europe from 2017 to 2021.Nevertheless, US investors...
